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Abstract

Increased activity of the alpha adrenergic nervous system
may be a significant factor promoting tissue ischemia in
endotoxic shock.

The suggestion that increased sympathetic

acti vi ty affects prostaglandin synthesis prompted investigation
of the potential interaction between the adrenergic nervous
system'

and arachidonic acid metabolites during endotoxemia and

septicemia.

In addition, the possibility that the underlying

patterns of arachidonic acid metabolites seen in two different
shock models may provide a rationale for therapeutic intervention
designed to block either or both the synthesis of arachidonic
acid metabolites or the activity of the adrenergic nervous system
was examined.

Studies were undertaken to determine the effects

of the alpha receptor antagonist, phenoxybenzamine (POB),
cyclooxygenase inhibitor,
thromboxane
shock.

(TxA2)

indomethacin

and prostacyclin

(PGI2)

Rats were pretreated with POB (1

( 10m g /k g i. v.) 30m in ute s p rio r

on plasma

in endotoxin-induced

mg/kg i.v.) and/or INDO

to i. v.

mg/kg s. enteritidis endotoxin (LDao).

(INDO),

and the

ad rn i n is t rat ion

0

f 8

Animals were bled at 30

minutes and 4 hours post-endotoxin for determination of blood
glucose,

plasma beta-glucuronidase

transferase
severity.

(AST),

(BG),

aspartate amino

and hematocrit as indicators of shock

Plasma was also taken at these

intervals

for

radioimmunoassay of the stable immunoreactive metabolites of TxA2
and PGI2,

iTxB2 and i6-keto-PGFla'

respectively.

Pretreatment

with INDO alone reduced endotoxin-induced hypoglycemia (P<O.05).
POB pretreatment reduced hypoglycemia, hemoconcentration and beta

i

glucuronidase (P<O.05).
in

the

improvement

(P<O.05).

The combination of POB and INDO resulted
of

all

these

indices

of

shock

severity

Rats pretreated with POB and INDO alone or conjointly

also exhibited significantly (P<O.05) enhanced survival compared
to shocked control rats.

Elevations in arachidonic acid

metabolites were attenuated by POB pretreatment.

In endotoxin-

treated rats (15 mg/kg i.v.), the mean plasma iTxB 2 value at 30
mins

post-endotoxin

was

1532

+

319

pg/ml

(N=1 0).

POB

pretreatment decreased iTxB2 to 719 + 114 pg/ml (N=10) (P<.05).
Plasma i6-keto-PGF1a

was increased at 4 hrs after endotoxin to

4161 + 885 pg/ml (N=5) in shocked controls.
increase

to

1184

+

363

pg/ml

(N=4)

POB attenuated this

(P<O.05).

The

da ta

demonstrate that the alpha receptor antagonist POB inhibits the
increased synthesis of arachidonic acid metabolites seen in
endotoxemia.

The reduction in more indices of shock severity in

rats receiving combined POB and INDO pretreatment suggest that
nonsteroidal anti-inflammatory agents may be an effective adjunct
to alpha adrenergic blocking agents in endotoxin shock.
Other experiments were undertaken to:
effects of POB and INDO,
(MAP),

heart

rate

1) determine the

individually, on mean arterial pressure

(HR),

and

MAP

respons;~

to

injected

no repinephr ine (NE) in control rats and endotoxin shocked rats,
2)

assess

synthesis,

the effect of POB on iTxB2 and i6-keto-PGF1a
and 3) determine the effects of POB and INDO,

independently and conjointly,

on survival from shock induced by

intraperitoneal injection of feces.

The data demonstrate that

POB (1 mg/kg) leads to a reduction in MAP in unshocked rats, but
does not significantly exacerbate endotoxin-induced hypotension.

ii

POB administration also effected a 60% - 90% reduction in the MAP
response to injection of NE in shocked and unshocked rats.

No

consistent effect on heart rate in shocked and unshocked animals
was observed with POB.

Pretreatment with INDO (10 mg/kg) did not

significantly alter MAP, HR, or the MAP response to exogenous NE
in normal rats and rats challenged with endotoxin.
In the intraabdominal sepsis model ( LD 100 within 48 hrs),
pretreatment with POB did not increase survival time while INDO,
independently or conjointly with POB, prolonged survival time
compared to controls and animals treated only with POB (P<0.05).
Treatments did not alter mortality (100% within 48 hrs).

The

effect of the combination of INDO + POB on survival time was not·
significantly different from that of INDO alone (P)O.OS).
Preliminary results suggest that POB pretreatment may suppress
the elevations of iTxB2 and i6-keto-PGF1a
The

in this shock model.

results are consistent with the hypothesis

prevailing plasma levels of iTxB2 and i6-keto-PGF1a'

that the
which have

different patterns in the two shock models studied, may playa
role in determining the therapeutic efficacy of POB.
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CHAPTER ONE

BACKGROUND AND SPECIFIC AIMS

__ ~NIFICANCE AND BACKGROUND
Septic and endotoxin shock are characterized by a series of
biological events including increased activity of the sympathetic
nervous system with catecholamine release,
system activation,

renin-angiotensin

disseminated intravascular coagulation (Ole),

lysosomal enzyme release, altered liver metabolism, hypoglycemia,
and production and release of prostaglandins (Wardle,
marked

increase

immediately

in

activity

following

the

of

the

endotoxin

1979).

The

sympathoadrenal system
insult

is,

in part,

a

protective response of the cardiovascular system to maintain
cardiac

output

vasoconstriction,

and

blood

pressure.

However,

intense

while ma1ntaining blood flow to vital organs

such as the brain and heart,

impairs perfusion of other vascular

beds such as the kidney and splanchnic viscera.

With progressive

ischemia of these tissues, and accumulation of metabolic products
in the later phases of shock, there is a reduction of myocardial
contracti li ty,
catecholamines,
clotting.

depressed vascu lar
and

increased

reacti vi ty to ci rculating

likelihood

of

intravascular

All of these contribute to terminal hypotension and

death (Sproul and Mullaney,

1974).

Sympathetic Involvement

Hyperactivation of the sympathoadrenal system

1S

generally

considered to be a major sequela of endotoxin shock, as suggested
by elevated plasma levels and tissue depletion of catecholamines
found in a variety of endotoxic models (Pardini et al., 1982).
Additional supporting evidence includes experiments involving
suppression of sympathetic activity and the use of adrenergic

1

receptor blockers (Lillehei et al.,

1972;

Filkins,

1979).

Investigations in which pressor drugs were used during
endotoxic shock appear to implicate sympathoadrenal hyperactivity
in

subsequent pathophysiology.

experiments

with

metarminol,

Lillehei

et al.

demonstrated

(1964),

that

in

additional

vasoconstriction in shock usually accelerates the onset of death.
Phenoxybenzarnine (POB) selectively binds to alpha adrenergic
receptors, increasing vessel diameter by reducing sympathetic
vasoconstriction.

Other vasodilator drugs, for the most part,

appear to be less effective in endotoxin shock because they
either

have

only

temporary

action

chronotropic effect (Hardaway, 1980).

or

exert

a

negative

A number of studies have

investigated the use of blocking agents such as POB to 1mprove
survival

in endotoxin shock.

In early shock when there

is

intensive vasoconstriction in organs excluding the heart and
brain, POB has been shown (Hardaway, 1980) to decrease pulmonary
hypertension,

peripheral resistance, and central venous pressure

while increasing cardiac index.
follow ing:

Other effects of POB include the

increasing renal plasma flow,

glomerular filtration,

and urine output (Vick, 1964); and improved GOT, and plasma K+
(Dadkar et al.,

1972).

8ruza's (1975)

experiment~

using POB have

likewise suggested that alpha blockade in endotoxin shock leads
to a

reduction

of splanchnic

ischemia.

Filkins

(1979),

in

comparing alpha and beta receptor blockade in endotoxin shock,
~eported

that alpha blockade resulted in a marked decrease in

thality while beta blockade sensitized the rats to endotoxin.
:his study emphasized the metabolic effects of alpha receptor
blockade,

resulting in enhanced gluconeogenesis.
2

Beta blockade,

in contrast, was associated with depressed gluconeogenesis and
hypoglycemia.
Although the preceeding suggest alpha receptor blockade
improves

an

organism's

defense

against

endotoxin,

investigators are in agreement.

Abrams et al.,

that

before

low

doses

of

POB

given

and

not

all

(1969) concluded

after

endotoxin

administration neither prevented death nor prolonged survival.
However,

Brake et aI,

(1964) suggest that POB,

although not

beneficial by itself, may ameliorate the pathophysiologic changes
in shock if given conjointly with additional treatment such as
plasma volume expanders.
The lack of agreement concerning the efficacy of POB in
shock therapy suggested by Brake et al.,

(1964)

may be a

consequence of a number of variables including differences in
type of shock and shock severity, different experimental animals,
different dosages of

the drug,

administration (Skjoldburg,

and different times of drug

1968).

Prostaglandin Involvement

In

addi tion

to

sympathoadrenal
p~asma

increased catecholamine release,

system
levels

acti vation

ot

and

prostaglandins

have been shown to be elevated during endotoxin shock (Isakson et
al.,

1977; Jakschik et al., 1974), and there is considerable data

suggesting their involvement in both endotoxin and septic shock
(Fletcher and Rarnwell,

1980ai

Bult and Herman,

1982).

These

studies have directed attention to the importance of two
metabo Ii te s

of

a rachidoni c

prostacyclin

( PGI 2).

ac i di

thromboxane A2

(TxA2)

and

These are potent vasoactive compounds and
3

mediators of platelet aggregation whose opposing effects
suggested a potential role in the cardiovascular sequelae of
shock.

Harris et al.,

(1980) have shown that increased levels of

PGI2 parallel the systemic hypotension in late shock, and that
the early plasma thromboxane concentration increase correlates
temporally with pulmonary hypertension.
involvement

of

these

metabolites

laboratories of Cook, Wise,
These

investigators

have

Further evidence for the

has

been

provided by

and Halushka (see review,

used

two

shock

models

to

the

1984).

examine

alterations in the TxA2/PGI2 ratio and the contribution of these
changes to the cardiovascular sequelae of shock.
In

the

rat

bolus

endotoxin

model,

increases markedly in the early phases,

plasma

i.e.,

thromboxane

within 30 minutes,

and then decreases by 4 hrs to control values while prostacyclin
levels, initially low, show a gradual increase to high levels in
late shock (Fig. 1 ; Cook et al., 1984).

A similar time course

of alterations in the ratio of thromboxane and prostacyclin has
a+so been reported for other species ranging from the baboon
(Harris et al., 1980) to the cat (Coker et al., 1981).

Selective

inhibition by several different chemical classes of thromboxane
synthetase

inhibitors

has

shown

improved cardiovascular

performance as well as improved survival (Tempel et al., 1982;
Cook et al., 1984).
and/or

platelet

These results suggest that the vasopressor
aggregatory

deleterious in endotoxin shock.

actions

of

thromboxane

are

Fig 1: Changes in plasma levels of iTxB2 and i6-keto-PGF1a
over the course of bolus endotoxin shock (reprinted with
permission from Cook et al.,1984).
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In contrast to the endotoxin model, shock induced by acute
abdominal sepsis in the rat is characterized by lower thromboxane
levels which are relatively unchanged throughout the course of
shock.

Prostacyclin increases early in shock to levels six to

eight times greater than that of thromboxane at most intervals

studied (Fig. 2; Cook et al., 1984).

The pattern of release of

arachidonic acid metaboli tes clearly differs in the two models.
Additionally, pretreatment with thromboxane synthetase inhibitors
is not protective in this septic model as it is in the endotoxin

model.

Thus, Tx synthetase inhibitors may be of no benefit in

shock states characterized by high PGI2/TxA2
noteworthy,

however,

that

cyclooxygenase inhibitors,

ratios.

treatment with

I·t is

fatty

acid

essential fatty acid deficiency,

and

antibiotic treatment do prolong survival (review by Cook et al.,
1984).

It has

also

been

reported that conjoint treatment,

gentamicin with either cyclooxygenase inhibitors or essential
fatty acid deficiency synergistically enhanced survival (Cook et
al.,

1984).

Thus it appears that the pattern of release of

arachidonic acid metabolites may dictate which and when
therapeutic interventions are most effective.
Interaction of Arachidonic Acid Metabolites and the Sympathetic
Nervous

System

The preceeding has documented both increased adrenergic
acti vi ty

and arachidonic acid

suggested a

metabolism

in

shock

and

has

major role of these vasoactive substances in

modulating vascular tone and hence, organ blood flow.

It is now

apparent that there is a complex interaction between various

5

Fig 2: Changes in plasma levels of TxB2 (hollow circles) and 6-

keto-PGF1a (solid circles) during fecal peritonitis
shock

(reprinted with permission from Cook et al.,

1984).
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vasoacti ve compounds such as catecholamines and prostaglandins.
Norepinephrine

has

been

shown

to

stimulate

release

of

prostaglandins from organs such as the kidney (Needleman et al.,
1974; Dunn et al., 1978), the heart (Needleman, 1974), and blood
vessels (Grodzinska and Gryglewski, 1980).

Neri Serneri et ale

--

(1981) noted that in many instances involving adrenergic
stimulation,

the ratio of TXA2/PGI2 was 1/35.

concentration of PGI2 compared to TxA2

The increased

was suggested to be

necessary to moderate the vasoconstriction response to adrenergic
As noted previously,

stimulation.

PGI2

is a potent vasodilator

with actions that oppose those of vasoconstrictor hormones.
Stimulation of arachidonic acid metabolism by vasoconstrictor hormones such as norepinephrine
of processes

mode rating

thei r

re lease

(NE)

or

may be a feature

vascula r

effects.

Prostaglandins may playa role in regulating vascular tone by
acting

directly

on

the

vascular

smooth

muscle,

modulating

sympathetic neurotransmission, or influencing the activity of
vasoactive compounds (Malik, 1978).

Evidence that endogenous

prostaglandins affect vascular

responsiveness

stimulation

from

derives

sympathetically
increasing or

largely

induced

decreasi~g

to adrenergic

experiments

vasoconstriction

is

in

which

modified by

arachidonic acid metabolism.

Inhibition

of cyclooxygenase with indomethacin and similar compounds has
increased

the

vasoconstriction

effected

by

sympathetic

stimulation or NE infusion in vascular beds ranging from the
spleen (Moncada and Vane, 1979) to the mesenteries (Malik et al.,
1976 ).

Goto

et

ale

(1 980)

suggested

that

indomethacin,

inhibiting prostaglandin synthesis, potentiated
6

by

responses to

elevated catecholamines induced by endotoxin shock,

thus

increasing vascular resistance and accelerating cell damage.
contrast,

By

increased prostaglandin synthesis by arachidonic acid

infusion

has

been

demonstrated

to

reduce

sympathetic

vasoconstriction response in these same beds (Moncada and Vane,
1979;

Malik et al.,

1976).

PGE1 and PGE2 have been shown to

interfere with sympathetic neuroeffector function by acting both
pre and post junctionallYi this direct effect on sympathetic
nerve stimulation was separated from any vascular effects that
these prostaglandins might have

(Hedqvist,

1971).

PGE thus

appears to act as a physiological brake mechanism for release of
catecholamines (Malik, 1978).

The concept which emerges from the

preceeding is that norepinephrine as well as other vasopressor
substances stimulate arachidonic acid

metabolism,

resulting in

the synthesis of prostaglandins which attenuate the
actions

of

the

catecholamines.

Thus,

this

pressor

stimUlation

of

arachidonic acid metabolism may be a factor in normal processes
maintaining circulatory homeostasis which, when altered as in
shock, may contribute to a failure of homeostasis and lead to
microcirculatory collapse.
The exact mechanism by which the catecholamine-induced
increase in prostaglandin synthesis occurs is not well known.
Levine and Moskowitz (1979) demonstrated a clear relationship
between norepinephrine and stimulation of prostaglandin synthesis
in canine kidpey cell cultures.

This stimulation of synthesis

could be blocked by a variety of alpha but not beta adrenergic
receptor blocking agents, thus implicating alpha receptors in

7

this

catecholamine

synthesis.

induced

stimulation of prostaglandin

By showing that synthesis of all arachidonic acid

metaboli tes appeared to be equally increased by norepinephr ine,
these investigators hypothesized that alpha receptor mediated
stimulation occurred at the level of cyclooxygenation of
~rachidonic

acid or deacylation of phospholipids.

Since

?henoxybenzamine blocked only the stimulation of prostaglandin
synthesis induced by norepinephrine,

in contrast to arachidonic

acid stimulation of prostaglandin synthesis,

Levine and

Moskowitz suggest that norepinephrine activates phospholipase A2
via an alpha receptor mediated process to liberate arachidonic
acid.
In Summary

1)

Sympathetic activity increases in shock; 2)

Thromboxane

and prostacyclin synthesis increases during shock in both of the
shock models described.

These two models differ in the pattern

of release of thromboxane and prostacyclin.

The endotoxin model

is characterized by a very low PGI2/TxA2 ratio in early phase of
shock which is reversed in the later phases, while the fecal
peritonitis

(septic)

model is characterized by a high PGI2/TxA2

ratio throughout the entire Course -of shock;

and~3)

Sympathetic

activity affects vascular tone and prostaglandin synthesis with
the latter acting to modulate the effects of sympathetic
stimulation.

8

Specific Aims

The objective of this study is to evaluate potential interactions between alpha adrenergic activity and prostaglandin
synthesis in the pathophysiology of endotoxemia and septicemia.
HYPOTHESES
I)

Increased activity of alpha adrenergic neurons plays a
role

in

modulating

thromboxane

A2

(TxA2)

and

prostacyclin (PGI 2 ) synthesis in endotoxic and septic
shock.
II)

The different patterns of release of arachidonic acid
metabolites in these two forms of shock will provide a
rationale for therapeutic intervention designed to block
either or

both the arachidonic acid cascade or the

activity of the adrenergic nervous system.
These hypotheses will be examined through experiments with
the following specific aims:
SPECIFIC AIMS
1)

To assess the effects of alpha receptor blockade with

phenoxybenzamine (POB) in endotoxic shock and shock resulting
from acute intra-abdominal peritonitis with regard to:
a) Survival time and mortality
b)

Plasma iTxB2 and i6-keto-PGFla

(stable immunoreactive

metabolites of TxA2 and PGI2).
c}

Indices of shock severity,

which include indicators of

hepatocellular dysfunction and lysosomal labilization,
hematocrit,

platelet and leukocyte counts.

2) To determine if the plasma levels of thrornboxane and
prostacyclin, as seen in the two different shock models, can be
9

used to dictate which therapeutic interventions

(POB and/or

indomethacin) are most effective.
3)

To determine if inhibitors of a!pha adrenergic activity,

as POB,

such

intervention

serve

as

a

beneficial

with cyc!ooxygenase

adjunct

inhibi tors,

to

therapeutic

i.e.,

indomethacin

(INDO) •

4)

To determine the effects of POB and INDO on various

cardiovascular parameters including mean arterial pressure, heart
rate,

and

mean

arteria!

pressure

response

norepinephrine in normal and endotoxin-treated rats.

10

to

injected

CHAPTER TWO

THE EFFECTS OF ALPHA ADRENERGIC BLOCKADE ON ARACHIDONIC
ACID METABOLISM AND SHOCK SEQUELAE IN ENDOTOXEMIA

INTRODUCTION

Increased activity of the sympathoadrenal system occurs in
endotoxin shock,

as demonstrated by both elevated plasma levels

and tissue depletion of catecholamines (Pardini et ale 1982;
Jones and Romano, 1984). The alpha adrenergic receptor blocker
phenoxybenzamine

has also been shown to improve survival in both

endotoxic and septic shock

(Lillihei et al.1972;

In addition to sympathoadrenal activation,

Filkins,

1979).

plasma levels of

arachidonic acid metabolites are elevated in endotoxin shock
(Fletcher and Ramwell, 1980a; Bult and Herman, 1982; Cook et
al.1984).

Studies with cyclooxygenase inhibitors or selective

thromboxane (Tx) synthetase inhibitors have implicated TxA21 a
potent vasoconstr ictor and platelet ag9regator and prostacyclin
(PGI 2 ),

a

potent

aggregation,

in

vasodilator

the

and

development

endotoxemia and sepsis.

inhibitor

of

certain

of platelet
sequelae

of

Both increased adrenergic activity and

arachidonic acid metabolism during endotoxin shock may therefore
be significant factors modulating vascular tone and organ blood
flow in shock.
It is now apparent that there is a complex interaction
between catecholamines and prostaglandins.
been shown to stimulate the
tissues such as the kidney

Nor~pinephrine

has

release of prostaglandins from

(Needleman et al.,

1974;

Dunn et

al.1978), heart (Needleman and Kaley, 1978), and blood vessels
(Grodzinska and Gryglewski, 1980).
reported

to

affect

Eicosanoids have also been

catecholamine

release

(Malik,

1978).

Stimulation of arachidonic acid metabolism by catecholamines may
thus be a

normal component of
11

the processes maintaining

circulatory homeostasis, and an imbalance in these systems during
shock may contribute to circulatory collapse.
These observations prompted the present study of the effects
of alpha adrenergic blockade on arachidonic acid. metabolism in
endotoxic shock.

Specifically, the effect of phenoxybenzamine on

survival time and mortality,

TxA2 and PGI2 synthesis,

shock severity was determined (Specific Aim 1).

and on

The relative

protective efficacy of phenoxybenzamine and indomethacin in
single and conjoint therapy on these parameters was also compared
(Specific Aims 2 + 3).

12

METHODS AND MATERIALS

Male Long-Evans rats (220-390) were

housed in plastic cages

and maintained under conditions of constant temperature and
controlled
libitum

illumination

as

was

food

Libertyville, Ill).
%

fiber,

(Wayne

light:
Feeds;

dark).

Water was ad

Allied

Mills,

Inc.

Food contained a minimum of 24% protein, 4.5

and 7% fat.

linolenic acid,

(12: 12:

Fats were 36.66% linoleic acid,

2.45%

and 4.16% arachidonic acid (composition data

supplied by the manufacturer).
Induction of Endotoxin Shock
Shock was induced

by a single bolus of bacterial endotoxin

(Boivin preparation of Salmonella enteritidis lipopolysaccharide;
lot #105-25 Difco Laboratories) via the dorsal vein of penis
during light ether anesthesia. An 8 mg/kg dose was used for the
studies to assess shock severity as well as survival time and
mortality.

A higher dose, 15 mg/kg, was used in experiments in

which iTxB2 and i6-keto-PGF, a were measured (vide infra).
dose was chosen to increase the

This

severity of shock and thus

maximize the potential differences in these metabolite levels
between the treatment groups.
Treatment Protocol
Phenoxybenzamine Hel (Smith, Kline and French) was freshly
prepared in 30% ethanol and isotonic saline and administered
intravenously at a dose of 1 mg/kg.

In separate experiments

(unpublished) mean arterial pressure responses to 0.02,
2.0 mg/kg norepinephrine were studied.
examined:

1}

0.2,

and

Three time points were

0.5 hi 2) 1 hi and 3) 4.5 h post-phenoxybenzamine
13

(corresponding to 0 min,
shocked animals,

30

respectively.

min,

and 4 h post endotoxin in

One mg phenoxybenzamine/kg body

wt. resulted in a greater than 60% reduction in the vasopressor
response to norepinephrine at all three time points in both
shocked and unshocked animals (P<O.05).

These data demonstrated

significant (P<O.OS) alpha receptor blockade with this dose,

and

did not exacerbate the hypotension observed in shock (P>O.05).
The cyclooxygenase

inhibitor

indomethacin

prepared in sodium phosphate (O.1M)
intravenously

(1 0

mg/kg).

This

was

freshly

(pH 8.0) and administered

dose has

been shown

in our

laboratory to result in complete blockade of arachidonic acid
metabolism by fatty acid cyclooxygenase

in both normal and

shocked rats (Cook et al., 1984).
Survival Time and Mortality
Rats

were

pretreated

with

indomethacin

and

phenoxy-

benzamine, singly or conjointly, 30 minutes prior to endotoxin
injection (8 mg/kg).

Determination of survival time was made by

observation as the rat progressed through a characteristic series
of symptoms including lethargy,

tachypnea,

loss of righting

reflex, convulsions, and respiratory arrest.
Parameters Used to Assess Shock Severity
Rats were pretreated with ei ther phenoxybenzamine,

(1

mg/kg), indomethacin (10 mg/kg), or vehicle 30 minutes prior to
endotoxin (8 mg/kg).

Four hours post-endotoxin, blood samples

were

the

collected from

inferior

analyses.
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vena cava for the various

Plasma beta-glucuronidase

(BG)

activity was measured

colorimetrically by modification of the procedure of Fishman et

ale (1967).

Plasma aspartate aminotransferase (AST) was measured

calorimetrically

(Sigma chemical bulletin No.

509).

Blood

glucose was determined on freshly drawn blood using Dextrostix
reagent strips with an Ames
Division,

Miles Laboratories,

reflectance
Inc.).

colorimeter

(Ames

Hematocrit was determined

by the micro method.

Radioimmunoassay of immunoreactive (i) iTxB2 and i6-keto-PGFla
Rats were pretreated with either phenoxybenzamine or a
vehicle solution 30 minutes pr ior to injection of endotoxin (15
mg/kg).

At 30 minutes and 4 hours post-endotoxin, approximately

5 ml of blood was collected from the inferior vena cava into

plastic

syringes

containing

0.1

ml

of

indomethacin-heparin

solution (2 mg of indomethacin; 5000 U of heparin dissolved in
one ml of 0.1

ml sodium phosphate buffer,

immunoreactive (i) "iTxB2 and i6-keto-PGFla

pH

8.0).

were measured using

previously described radioimmunoassays (Burch et al.,
et al.1980).

Plasma

1979; Wise

Blood was centrifuged (1500 x g) for 20 mins, and

the plasma collected and frozen at -20 o C until extraction.
...

:0:-

minimal detectable amount of iTxB2 and i6-keto-PGFla
plasma was approximately 200 pg.

The

Neither

phenoxybenzamine demonstrated cross

in 1 ml of

indomethacin nor

reactivity in either

radioimmunoassay.
STATISTICAL ANALYSIS
Indicators of shock severity were examined by analysis of
variance-completely random design (ANOVA-CRD).
15

The Newman-Keuls

test was used to examine differences between treatment groups.
Geehan's Generalized Wilcoxon Test (Knapp and Wise,1985) was used
for

the

surv i val

tirne/mortali ty

studies,

and

the

unpai red

Student's t-test was used for examining differences in eicosanoid
concentrations between two treatment groups.

All data were

expressed as mean + standard error of the mean and confidence
limits were set at 95% for significance.
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RESULTS
Plasma Arachidonic Acid Metabolites
Previous studies have demonstrated non-detectable levels of
iTxB2 and i6-keto-PGF1a in rats prior to induction of endotoxic
shock

(Cook et al.,

1984; Wise et al.,

1980).

Rats receiving

vehicle and admi ni ste red endotox in (1 5 mg/kg) e xhi bi ted plasma
iTxB2 levels of 1532 + 319 pg/rnl at 30 minutes post-endotoxin,

and 1131

+ 135 pg /ml at 4 hou r s

pretreatment signif icantly
iTxB2

to

719

(approximately

+

114

40%

(F i

(P<O.O 5)

pg/ml

at

Phenoxybenzamine

blunted the elevated plasma
30

reduction).

g 3).

minutes

However,

post-endotoxin

at 4 hours,

iTxB2

concentrations in the phenoxybenzamine treatment group were not
different from the vehicle group (P>0.05).
There was no difference in plasma concentrations of i6-ketoPGFla demonstrated between the controls (811 + 108 pg/ml) and the
phenoxybenzamine (615 + 93 pg/ml) group at 30
endotoxin administration (Fig 4).
endotoxin,

the

However,

minutes after

at 4 hours post-

plasma concentrations of i6-keto- PGF 1a

in the

phenoxybenzamine group were only 30% of those of the controls
(P<O.05 ).

Plasma

i6-keto-PGF1a was

1184 + 363 pg/ml in the

phenoxybenzamine pretreated group compared to the untreated group
mean of 4161 + 885 pg/ml.
Survival Time and Mortality
Pretreatment

with

vehicle

30

minutes

before

endotoxin

challenge (8 rng/kg) resulted in a 77% mortality ( LD 80) with a
mean

survival

time

of

9.5+1.8

hours

(F ig

5).

By

contrast,

indomethacin pretreatment resulted in a significant reduction in

17

Fig 3.

Plasma iTxB2 concentrations during endotoxin shock.
(1 mg/kg) or POB vehicle (CONTROL)

POB

was administered

30

minutes before i.v. administration of S. enteritidis
endotoxin (15 mg/kg).

Plasma samples for iTxB2 were

collected at 0.5 and 4 hrs post-endotoxin.
represent mean +

SEM

( ) = Number of rats.

*

p

< 0.05 compared to controls.
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Fig 4.

Plasma i6-keto-PGF1a concentrations during endotoxin
shock.

POB (1 mg/kg) or POB vehicle (CONTROL) was

administered

30

minutes before i.v. administration of

enteritidis endotoxin (15 mg/kg).

s.

Plasma samples for

i6-keto-PGFla were collected at 0.5 and 4 hrs postendotoxin.

Bars

represent

Number of rats.

*

p < 0.05 compared to controls.
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Fig 5.

Percent survi val in rats subjected to endotoxin shock.
Rats were pretreated with indomethacin (INDO; 10 mg/kg),
INDO

vehicle,

phenoxybenzarnine (POB;

1 mg/kg),

POB

vehicle, or INDO and POB (I + P) i.v. 30 minutes before
~

enteritidis endotoxin (8 mg/kg).

controls.

Bars represent percent survival ( ) = Number

of rats.

* = p < 0.05

CONTROL = unshocked

compared to controls.::
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mortality to 36%,
18.2+6. 1 hours

and an increase in mean survival time to

(P<O.O 5 ).

Pretreatment with phenoxybenzamine

reduced mortality to only 12% in response to endotoxin (p<O.05).
The combination of phenoxybenzamine and indomethacin decreased
mortality to 9%.

No significant differences were observed

between the indomethacin, phenoxybenzamine, and phenoxybenzamine

+ indomethacin treatment groups (P>O.OS).
Indices of Shock Severity
Rats given 8 mg/kg of endotoxin and vehicle exhibited the
follow ing at four hours post-endotoxin:

hypoglycemia,

hematocrit, and increased plasma levels of AST and BG.
1-2).

elevated
(Tables

Indomethacin prevented only the hypoglycemia (p<O.05).

Pretreatment
improvement

with phenoxybenzamine

(P<O.OS)

resulted

in

significant

in the hypoglycemia and hemoconcentration.

Treatment with indomethacin or phenoxybenzamine alone had no
significant effect on plasma AST or BG.
Treatment with the combination of phenoxybenzamine and
indomethacin 30 minutes before endotoxin resulted in improvement
of blood glucose, plasma AST, BG, and hematocrit.
the indicators of shock severity,

no

signifi~ant

For each of
difference

between pretreatment with phenoxybenzamine and pretreatment with
the combination of phenoxybenzamine and indomethacin was observed
(P>O.05).

However,

conjoint administration of phenoxybenzamine

and indomethacin provided more protection than either agent used
alone as suggested by the greater number of indices of shock
severity in which a significant improvement occurred.
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TABLE I
Effects of Phenoxybenzamine (POB) and Indomethacin (INDO)
Pretreatment on Hypoglycemia and Alterations in Plasma
AST Induced by Endotoxin

Group

Blood Glucose
(mg%)

Plasma AST
(S.F.

Uni ts/ml)

Control + Endotoxin

23 +

-

8

(4 )

580 + 134 ( 4 )
-

INDO + Endotoxin

73 +
-

8

(5)*

324 + 101

(5 )

POB + Endotoxin

64 + 20

(4)*

224 +

37

(4)

(4)*

174

POB + INDO + Endotoxin

-

101 +

Data expressed as mean + S.E.

-

5

-

-+

9 (9) *

(N)

INDO (10 mg/kg), INDO vehicle, POB (1 mg/kg), and/or POB
vehicle were administered 30 minutes before S. enteritidis
end 0 to x i n (8 m9 /k 9 , i. v. ) •
Samples were collected 4 hrs post-endotoxin.

*

P<O.05 compared to control + endotoxin

TABLE II
Effects of Phenoxybenzamine (POB) and Indomethacin (INDO)
Pretreatment On Alterations In Hematocrit
and Plasma Beta-Glucuronidase

Group

(BG)

Induced by Endotoxin

Hematocrit

Plasma BG

(%)

(units/ml)

+ 1 (4)

499 + 145 (4 )

Control + Endotoxin

53

INDO + Endotoxin

46 + 1

POB + Endotoxin
POB + INDO + Endotoxin

168 +
-

27

43 + 4 (4)*

237 +

82 (4 )

40 + /l

130 +
-

18

(5)

(1)*

-

(5 )

(4 )

*

)/

Data expressed as mean~.E.

(N)

INDO (10 mg/kg), INDO vehicle, POB (1 mg/kg), and/or POB
vehicle were administered 30
minutes before S. enteritidis
end 0 t 0 x i n (8 m9 /k 9 , i. v • ) •
Samples were collected 4 hrs post-endotoxin.

*

P<O.05 compared to control + endotoxin
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DISCUSSION

Nickerson and Carter (1959) were among the first to propose
the use of phenoxybenzarnine as an anti-shock agent.

However, the

use of vasodilators such as phenoxybenzarnine in septic shock, as
well as other forms of shock, has been controversial (Abrams et
al.1969; Brake et al., 1964).
been

the

prevention

of

The rationale for their use has

ischemic

vasoconstr iction,

thereby

maintaining flow despite the potential for further hypotension.

By sustaining the match between tissue metabolism and perfusion,
vasodilators may therefore prevent the ischemia which leads to
increased capillary permeability,
loss

of

blood

volume

and

vasodil~

blood

pressure

subsequent

(Lillihei,

1979).

Salutary actions of phenoxybenzamine in endotoxin shock include
metabolic as well as hemodynamic influences as indicated by a
study in which alpha adrenergic blockade was associated with
decreased

hypoglycemia

endotoxernia (Filkins,

and

enhanced

gluconeogenesis

during

1979).

This study demonstrates that pretreatment with phenoxybenzarnine and indomethacin are individually protective in shock
induced by an

LDao

dose of endotoxin as shown by improvement in

survival and indicators of shock severity.
severity

showed

no

significant

Although indices of

differences

between

the

indomethacin and phenoxybenzamine treatment groups,

the

combination of these drugs reduced more shock severity parameters
than either drug alone.
Our results agree, in part, with the previous report of Goto
et

al

(1980)

that

indomethacin

19

may

make

a

significant

contribution as an antishock agent when

perip~eral

maintained, as with phenoxybenzamine.
indomethacin,

It

~s

circulation is

suggested that

by inhibiting prostaglandin synthesis,

may

potentiate vascular reactivity to catecholamines during endotoxin
shock,

thus increasing vascular resistance and accelerating cell
Chapnick et al.,

damage.

(1976) and Gryglewski and Kobut (1975)

in studies of the feline kidney and rabbit ear have reported that
prostaglandin synthesis moderates the
norepinephrine.

vasoconstrictor action of

Hall and Hodge (1971) have also presented data

suggesting that cyclooxygenase

inhibition potentiates

response of catecholamines in endotoxic shock.
Feuerstein et a1.(1981)

demonstrated that the

the

By contrast,

beneficial action

of indomethacin in endotoxic shock is associated with reduced
plasma elevations of norepinephrine and epinephrine.

It was

concluded in the latter study that the superior hemodynamic state
in indomethacin-protected cats challenged with endotoxin resulted
in a

reduced stimulus for sympathetic stimulation.

recently,

Fink

et

ale

(1985)

have

demonstrated

More

diminished

sensitivity to norepinephrine and angiotensin II in the septic
rat which

is

restored toward normal

by

indomethacin.

They

suggested that this decreased pressure responsiveness is mediated
by vasodilating prostaglandins released during sepsis.
It is now apparent that arachidonic acid metabolites have
both facilitatory and inhibitory modulating effects on adrenergic
neurotransmission.

For example,

prostaglandins of the F series

enhance vascular reactivity produced by sympathetic stimulation,
as well as the release of catecholamines from the adrenal medulla
(Brody

and

Kadowitz,1974).

The
20

prostaglandin

endoperoxide

analog, U-46619, and the TxA2 mimetic, carbocyclic TxA21 also
potentiate responses to norepinephrine in vascular muscle tissue
and rat anoccygeus muscle (Makita, 1983; Timimi et al., 1978).

By contrast, prostaglandins of the E series inhibit adrenergic
nerve transmission (Malik, 1978; Timimi et a1., 1978; Hedqvist,
1977).

Hedqvist (1977) reviews the large number of tissues where

PGE's are potent inhibitors of neurally released NE release,
suggests a

local PGE-mediated feedback mechanism.

and

As suggested

by both this investigator and the preceeding, arachidonic acid

metabolites either inhibit or facilitate adrenergic neurotransmission depending on the eicosanoid predominantly synthetized and
its level of synthesis.
Reductions in both iTxB2 at 0.5 hrs after endotoxin and i6keto-PGF1a at 4 hours post-endotoxin occurred after pretreatment
with phenoxybenzamine

(approximately 40% and 70%,

respectively).

Whether this is a result of a direct effect on arachidonic acid
metabolism or is a nonspecific response to a reduction in shock
severity remains to be determined.

Previous in vitro studies,

however, have demonstrated phenoxybenzamine-mediated reduction of
prostaglandin synthesis b·y rat peri toneal nl'acrophages in response
to norepinephrine and endotoxin (Tempel et al.,

1984),

and by

Madin-Darby canine kidney cells in response to norepinephrine
(Levine

and

Moskowitz,

1979).

One

must

also

consider

the

possibility that phenoxybenzamine may have acted to delay rather
than suppress the elevations in iTxB2 and i6-keto-PGFla.

In conclusion, our results suggest that a salutary action of
phenoxybenzamine during endotoxic shock may be mediated,

21

in part,

by a

reduction of arachidonic acid metabolism in addition to

attenuating the expression of alpha adrenergic activity.

The

improvement in more indices of shock severity following conjoint
phenoxybenzamine and

indomethacin

treatment also

suggests

that

cyclooxygenase inhibitors may be an effective adjunct with alpha
adrenergic blockade in endotoxin shock.
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CHAPTER THREE

THE EFFECTS OF PHENOXYBENZAMINE AND INDOMETHACIN ON MEAN
ARTERIAL PRESSURE, HEART RATE, AND MEAN ARTERIAL PRESSURE
RESPONSE TO INJECTED NOREPINEPHRINE IN NORMAL AND ENDOTOXIN
-TREATED RATS

INTRODUCTION

Initial studies of alpha receptor blockade with 1 mg/kg
phenoxybenzamine (POB) in endotoxin shock in the rat have shown
decreased shock severity,

improved survival time, and attenuated

levels of iTxB2 and i6-keto-PGFla '

the stable immunoreactive (i)

metabolites of thromboxane and prostacyclin, respectively.
investigations raised the following questions:

1)

These

What degree

of alpha receptor blockade is effected by this dose?; 2)
endotoxin influence the degree of receptor blockade?;

Does
and 3)

What is the influence of POB on mean arterial pressure and heart
rate

over

the

course

of

shock

in

our

rat

endotoxin

model?

Similar questions arise regarding the effect of indomethacin
(INDO) pretreatment (10 mg/kg) on mean arterial blood pressure
and heart rate over the course of shock in our endotoxin model.
With increased sympathetic activity during endotoxin shock
(Pardini

et al.,

1982),

INDO

may alter

pressure

response to catecholamines by

mean arterial blood

removing the

influence of prostacyclin and/or other eicosanoids.

inhibitory
Gullner et

al., (1983 review) report that observations of the interaction
between prostaglandins and the adrenergic nervous system are
conflicting.

!..n vit!:o,

prostaglandin"s generally inhibit

norepinephrine release and adrenergic neurotransmissioni

they appear to promote the release of norepinephrine.
for these conflicting results is unknown.

in vivo,
The basis

These investigators

suggest that the physiologic significance of the inhibitory
actions of prostaglandins on transmitter release observed in
vitro may apply only in states of increased sympathetic activity.
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The purpose of this phase of the the study is:

1)

To

characterize the extent of alpha receptor blockade in unshocked
and shocked animals; 2)

To determine the influence of POB (1

mg/kg) and INDO (10 mg/kg) on mean arterial blood pressure and
heart rate over the course of shock;

and 3)

To examine the

influence of INDO on the mean arterial blood pressure responses
to graded doses of norepinephrine in the rat model of bolus
endotoxin shock (Specific Aim 4).
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METHODS AND MATERIALS

Animals
(See methods and materials of Chapter Two)
Surgery and Anesthesia
Long-Evans rats were anesthetized with 200 mg/kg Ketamine
HCI

(Vetalari

Parke-Davis,

Morris Plains,

NJ).

A cervical

midline incision was made, and the carotid artery and jugular
vein

were

cannulated

with

polyethylene

tubing

(PE

50)

for

drug/endotoxin administration and recording of blood pressure and
heart rate.
Blood Pressure and Heart Rate Recording
A Grass Model 7 oscillographic recorder (Quincy,

MA)

and

Statham pressure transducer (model P23Dc, Puerto Rico) were used
to monitor blood pressure and heart rate over the course
shock.

of

The carotid catheter was connected to the pressure

transducer, and blood pressure and heart rate were monitored.
When a stable blood pressure was observed for a minimum of five
minutes, experiments were begun. Mean arterial pressure (MAP) was
obtained electronically.

The heart rate (HR) was calculated at

various intervals throughout the course of shock:
before

POB,

(immediately

INDO,
before

or "vehicle
endotoxin

immediately

adminis'tration,
administration),

0

minutes

30

minutes

(immediately before Group A, NE challenge), and 4 hours postendotoxin (immediately before Group B, NE challengeisee Figure
6)•

POB, INDO and Endotoxin Administration
The same protocol for administration of POB,
25

INDO,

and

Fig 6.

Description of experimental protocol.

Half of the rats

were monitored to 30 minutes post-endotoxin and then
subjected to norepinephrine (NE) challenge (Grp A).

The

other half were monitored to 4 hrs post-endotoxin and
then challenged with NE (Grp B).

Mean arterial pressure

was recorded immediately after phenoxybenzamine

(MAP)

(POB),

indomethacin

(INDO),

or vehicle

immediately before endotoxin

(e)

(V) at -

30

mins,

or vehicle (C) at 0

mins, at 30 mins (immediately before NE challenge in Grp
A rats),

and at 1, 2, 3, and 4 hrs post-endotoxin

(immediately before
rate

(HR)

NE

challenge in Grp

B

rats).

Heart

was recorded at all of the same time points as

MAP except at 1, 2, and 3 hrs post-endotoxin.
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endotoxin

as

for

Chapter 2

was

used with the

exceptions:

injections were via the jugular cannula rather than

the dorsal vein of the penis and 20
See

Table

III

for

description

following

mg endotoxin/kg was used.
of

groups

used

in

these

experiments.
Norepinephrine Challenge
To determine the extent of alpha receptor blockade, the MAP
response to three logarithmic doses of norepinephrine (NE) was
examined at 30 minutes and 4 hours post-endotoxin.

These time

points were chosen to correlate with the iTxB2 peak at 30 mins
post-endotoxin and the high i6-keto- PGF la
post-endotoxin in our model (Cook et al.,

levels seen at 4 hours
1984).

These were also

the times at which plasma was collected for assay of iTxB2 and
i6-keto-PGF1a

in earlier experiments (Chapter 2).

The 4 hours

post-endotoxin time point was also used in the previous
experiment (Chapter 2) to assess the degree of shock severity.
Preliminary studies indicated the adequacy of the doses selected
to produce graded increases in mean arterial pressure.

The 0.02,

0.2, and 2.0 mg/kg doses were given as a bolus injection starting
with the lowest dose followed by an isotonic saline flush.

After

observing the peak MAP response within 5-15 seconds, the next
dose was administered after the MAP returned to baseline levels.
The NE solutions used were prepared from the bitartrate salt
dissolved in a 0.9% saline solution.

Dilutions from the stock

solution were made, and aliquots of the three logarithmic doses
were frozen.

One hour before NE was administered, the solutions

were allowed to thaw and warm to room temperature.
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TABLE III
Treatment Groups Used in Experiments

Treatment Group

Abbreviation

Endotoxin vehicle + POB vehicle

=

Endotoxin + POB

= Grp C + P

Endotoxin + POB vehicle

=

Endotoxin + POB

= Grp

E

Endotoxin vehicle + INDO vehicle

= Grp

C + V

Endotoxin vehicle + INDO

=

Endotoxin + INDO vehicle

= Grp

Endotoxin + INDO

= Grp E + I

Grp C + V

Grp E + V

+

P

Grp C + I
E

+ V

The first four groups, C+V, C+P, E+V, and E+P were
subdivided into Group A (monitored to 30 rnins postendotoxin and then challenged with NE) and Group B
(monitored to 4 hrs post-endotoxin and then challenged
with NE).
The last four groups (INDO or INDO vehicle)
were monitored only to 30 mins post-endotoxin before NE
challenge.
Endotoxin = E, Endotoxin vehicle = C, indomethacin =
INDO, phenoxybenzamipe = POB, POB or INDO vehicle = V.
-

'
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Statistical Methods
Differences in MAP and HR at selected time points of the
experimental period and differences in MAP

response to injected

NE between the treatment groups were examined by analysis of

variance-randomized complete block design (ANOVA-ReBD).

All data

are expressed as mean + standard error of the mean,
confidence limits were set at 95% for significance.
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and

RESULTS

Animals observed to 30 mins post-endotoxin

=POB Group A

Mean arterial pressure of the four groups did not differ at
30

minutes prior to endotoxin administration,

before POB or vehicle injection (Fig. 7).

i.e.,

immediately

Unshocked controls

(Group C+V) exhibited a stable MAP over the experimental period
(94 + 9 initially,
vehicle).
of MAP

104 + 11

mm Hg at 30 mins post-endotoxin

Pretreatment with POB led to 30 and 22 mm 8g reduction

from control values

in C+V

immediately prior to endotoxin,

and E+V

groups

respectively.

examined

At 30 minutes

post-endotoxin, the shocked animals, Groups E+V and E+P, 63 + 15
and 59 + 7 respectively,

had significantly lower pressures than

the unshocked controls of Group C+V (94 + 9).

There was,

however, no significant difference (P>0.05) between Groups E+V
and E+P, suggesting that POB did not exacerbate the endotoxininduced hypotension.
There were no significant differences in HR between the four
treatment groups at the time points observed except between POBtreated animals subjected to endotoxin (Grp C+Pi Table IV) and
unshocked controls (Grp C+ViTable IV).
Animals subjected to NE challenge 30 minutes post-endotoxin
or endotoxin vehicle (Fig. 8) showed a 22+ 8, 40 + 12, and 73 +
10 mm 8g increase in MAP in response to 0.02, 0.2, and 2.0 mg/kg
of injected NE.

In contrast,

POB pretreated animals showed

approximately a 90% reduction in the response, 5 + 5, 5 +6, and 2
+

3,

respectively

(P<O.OS).

Endotoxin-treated

controls

demonstrated approximately a 60% reduction in response to NE, 9 +
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Fig 7.

Mean arterial pressure at - 30 mins, 0 mins, and 30 mins
post-endotoxin.

Rats were pretreated with POB (1 mg/kg)

or vehicle (V) 30 minutes S. enteritidis endotoxin (E;
mg/kg) or vehicle (e).

N= 5 for each group_
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TABLE IV
Effects of POB and Endotoxin on Heart Rate in
Rats Observed to 30 Minutes Post-endotoxin

Group

o

-30 mins

mins

30 mins

Group C + V

334 + 28

335 + 32

322 + 32

Group C + p

289 + 6

266 + 13

255 + 11

Group E + V

331 + 30

323 + 41

355 + 10

Group E + P

353 + 30

320 + 19

347 + 6**

Data expressed as mean + S.E.
Heart rate at - 30 mins, 0 mins, and 30 mins post-endotoxin.
Rats were pretreated with POB (1 mg/kg) or vehicle (V) 30 mins
before S. enteritidis endotoxin (Ei20 mg/kg) or vehicle (C).
N=5 for-each group.

** p < 0.05 (ANOVA) compared to rats treated with POB and
endotoxin vehicle (Grp C+P).

28c

Fig 8.

Mean arterial pressure response to three logarithmic
doses of NE (0.02, 0.2, and 2.0 mg/kg) at 30 mins postendotoxin.

Rats were pretreated with POB (1 mg/kg) or

vehicle

30 mins before

(V)

20 mg/kg) or vehicle (C).

*

**

s.
N

enteritidis endotoxin

=5

(Ei

for each group_

P<0.05 (ANOVA) compared to controls.
P<0.05 (ANOVA) compared to controls and rats treated
with only POB.
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5,
POB

15 + 6, and 43 + 18 (P<0.05).

Shocked rats pretreated with

(Group E+P) were significantly (P<0.05) reduced in response

to NE compared to rats given endotoxin alone only at the 2.0
mg/kg

dose

of

significantly

NE.

However,

lower MAP

these

response

animals

at all

exhibited

three

a

doses of NE,

approximately an 85% reduction compared to the unshocked controls
of Group C+V.
Animals observed to

!

hours post-endotoxin

=

POB Group B

Mean arterial pressure examined at four hours post-endotoxin
showed

no

treatment

significant
groups

(F ig.

difference
9).

(P>O.05)

Unshocked

between

controls,

the

four

Group

C+V,

exhibited a stable MAP (91 + 8 and 98 + 15 mm Hg throughout
4.5 hour experimental period.

the

Pretreatment with POB alone did

not significantly reduce MAP in Group C+P animals either prior to
or 30 minutes post endotoxin vehicle administration (78 + 4 and
73

+

8 vs.

91

+ 8 and 92 +

12,

respectively).

administration did not significantly reduce

in Groups E+V

MAP

and E+P animals compared to unshocked controls.

Endotoxin

Mean arterial

pressures of shocked rats treated with POB and endotoxin were not
significantly different from animals given only endotoxin (Fig.
9).
to

POB did not therefore effect a
values

below

those

of

reduction in blood pressure

respective

unshocked

and

shocked

controls.
Heart rate in POB-treated rats given endotoxin (Grp E+Pj
Table V) was significantly different (P<O.OS) from both unshocked
controls (Grp C+V) and rats given only POB (Grp C+P) at 4 hours
post-endotoxin.

There were no other significant differences
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in

Fig 9.

Mean arterial pressure at -

30 mins, 0 mins, 30 mins, 1

hr, 2 hrs, 3 hrs, and 4 hrs post-endotoxin.
pretreated with POB (1
before
(C).

s.
N

=

mg/kg) or vehicle (V) 30 mins

enteritidis endotoxin (Ej
6 for each group.
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Rats were

20 mg/kg) or vehicle
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TABLE V
Effects of POB and Endotoxin on Heart Rate in Rats
Observed to 4 Hours Post-endotoxin

Group

o mins

-30 mins

4 Hrs

Group C + V

325 + 14

298 + 10

302 + 13

Group C + p

313 + 23

261

+ 25

322 + 32

Group E + C

376 + 20

353 + 23

336 + 14

Group E + P

368 + 32

292

+ 18

399 + 14***

Data expressed as mean + S.E.
Heart rate at - 30 mins, 0 mins, and 4 hrs post-endotoxin.
Rats were pretreated with POB (1 mg/kg) or vehicle (V) 30
min s be for e S • en t e r i tid i 5 end 0 t 0 x i n (E; 20m g /k g ) 0 r
vehicle (e). N= 6 for each group.
*** P <0.05 (ANOVA) compared to controls
treated with only POB (C+P).
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(C+V) and rats

HR between the four treatment groups.
Unshocked controls showed a 35 + 16, 45 + 12, and 85 + 9 mm
Hg response to the increasing doses of NE at 4 hrs post-endotoxin
(Fig 10).

POB pretreatment alone (Group C+P) resulted in

approximately a 65% reduction in the MAP response to three doses
of NE (13 + 4,15 + 9, and 28 + 9 mm Hg).

Endotoxin alone (Group

E+V) resulted in a 40% reduction of the MAP response to all three
doses,

9

+

9,

25

+ 15,

and 53

+ 28,

respectively

(P<O.05).

Shocked rats treated with POB showed a greater than 70% reduction
in the MAP

response to NE

compared to control rats;

(3 + 3,
(P<O.05).

7 + 5,

and 25 + 9 mm H9

There was no significant

difference in the response to NE of animals given endotoxin alone
(Group E+V)

and animals given POB and endotoxin (Group E+Pi

(P<0.05).
Animals observed to 30 mins post-endotoxin

=INDO Group A

The unshocked controls, Groups C+V (Fig. 11), exhibited a
stable MAP of approximately 100
observation
inhibitor,

period.
INDO,

Pretreatment

mm 89 over the 1.5 hour
with

the

cyclooxygenase

did not significantly alter MAP.

Endotoxin

resulted in a decrease in MAP at 30 mins post-endotoxin in Groups
E+V and E+I compared to unshocked controls (72 + 12 and 78 + 12
vs. 97!. 8 and 85 + 12 mm Hg).
Neither INDO nor endotoxin had any effect on HR.

No

significant differences were observed between any of the four
treatment groups at the three time points (Table VI).
Unshocked controls exhibited a dose-response increase in
response to NE similar to the previous experiment (20 + 10, 37

30

!.

Fig 10. Mean arterial pressure response to three logarithmic
doses of NE
endotoxin.

(0.02,

0.2,

and 2.0 mg/kg) at 4 hrs post-

Rats were pretreated with POB (1 rng/kg) or

vehicle (V) 10 mins before S. enteritidis endotoxin

20 mg/kg) or vehicle (C).

*
**

N

=6

(Ei

for each group.

P<0.05 (ANOVA) compared to controls.
P<O.05 (ANOVA) compared to controls and rats treated
with only POB.
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Fig 11. Mean arterial pressure at - 30 mins, 0 mins, and 30 mins
post-endotoxin.
mg/kg) or vehicle

Rats were pretreated with INDO
(V)

30 minutes before

endotoxin (Ei 20 mg/kg) or vehicle (e).
group.
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TABLE

VI

Effects of INDO and Endotoxin on Heart Rate in
Rats Observed to 30 Minutes Post-endotoxin

-30 mins

o mins

30 mins

Group C + V

353 + 25

347 + 24

330 + 29

Group C + p

346 + 21

319 + 16

291 + 21

Group E + V

323 + 25

339 + 24

294 + 7

Group E + P

344 + 28

329 + 20

279 + 17

Group

Data expressed as mean + S.E.
Heart rate at - 30 mins, 0 mins, and 30 mins post-endotoxin.
Rats were pretreated with INDO (10 mg/kg) or vehicle (V) 30
mins before S. enteritidis endotoxin (Ei 20 mg/kg) or
vehicle (C). N= 6 for each group.

3ue

Fig 12. Mean arterial pressure response to three logarithmic
doses of

NE

(O.02,

post-endotoxin.
mg/kg) or vehicle
endotoxin

(ei

0.2,

and 2.0 mg/kg) at 30 minutes

Rats were pretreated with INDO (10
(V)

30 mins before S.

20 mg/kg) or vehicle (C).

group.
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13, and 71 + 8 mm Hg, respectively; Fig. 12).

Pretreatment with

INDO had no effect on the response to NE (P>0.05).
to the earlier results,

In contrast

the endotoxin-induced attenuation of the

MAP response to NE was not found at any of the three doses of NE
(17 + 4,30 + 7, and 72 + 7 mm Hg).

INDO pretreatment failed to

alter the response of shocked animals to
controls (13 + 10,28 + 7, and 73

2: 12 mm

NE

compared to shocked

Hgi P>O.05).

Because

of the lack of influence of INDO on hemodynamic parameters and
response to

in animals observed to 30 mins post-endotoxin, no

NE

effort was made to extend these studies to

four hours post-

endotoxin.
Summary
1.

POB leads to a reduction in MAP in unshocked rats, but does
not significantly exacerbate endotoxin-induced hypotension.

2.

Administration of 1 mg/kg POB effected a 60-90% reduction in
the MAP response to injected NE in shocked and unshocked
animals,

3.

respectively.

Endotoxin alone

resulted

in a 40%-60% reduction in the

magnitude of the MAP response to injected NE compared to
controls.
~

4.

INDO pretreatment has no significant effect on MAP or HR at
any of the three time points observed up to 30 mins postendotoxin in unshocked and shocked rats.
significantly

5•

POB

and

INDO also did not

affect the MAP response to injected NE.

endotoxin,

given

individually,

did

not

significantly affect HR at the time points up to 4 hrs postendotoxin.

Endotoxin administration in POB-pretreated rats

31

resulted in a significant increase in
given

only POB

at

30

mins

HR

compared to rats

post-endotoxin,

and

to both

unshocked controls and rats given only POB at 4 hrs postendotoxin.
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DISCOSSION

The use of vasodilators such as POB in septic shock, as well
as other forms of shock,

has been fraught with controversy

concerning their efficacy (Abrams et al., 1969; Brake et al.,
1964).

The rationale for the use of vasodilators is that despite

the potential for further hypotension, by preventing excessive
vasoconstriction they maintain tissue perfusion.
better

match

between

tissue

metabolism

By effecting a
and

perfusion,

vasodilators thus prevent the ischemia leading to increased
capillary permeability, vasodilation, and subsequent loss of
blood volume and blood pressure (Lillihei, 1979).
Previous experiments (Chapter 2) have suggested that an
additional beneficial effect of POB is the attenuation of the
synthesis

of arachidonic acid metaboli tes,

thromboxane and

prostacyclin, which have been implicated in pathophysiology of
endotoxin shock (Cook et al.,

1984).

Results of these experiments suggest that the 1 mg/kg dose
of POB effected a

60-90%

reduction in the MAP

response to

injected NE in both control animals and animals subjected to
endotoxin.

Although the administration of POB to unshocked rats

resulted in depression of MAP in some instances compared to
unshocked controls, this dose did not increase the endotoxininduced hypotension, a potential cardiovascular side effect that
may have contraindicated the use of POB.
The MAP

response

to NE

was

not

completely

suppressed

suggesting that not all alpha receptors were saturated.
dose was,

however,

This

sufficient to significantly suppress the

production of iTxB2 and i6-keto-PGF1a ' resulting in decreased
33

shock severity and increased survival time.
experimental

use

of

different

animals

In addition to the
and

shock

models,

variations in the dose and time of drug administration may also
be important determinants of the outcome

(Skjoldburg,

Preliminary work in our laboratory suggests that POB

1968).
has no

salutary actions in a fecal peritonitis model of septic shock
(Chapter 4).

This model,

in contrast to the endotoxin model,

is

characterized by a high prostacyclin/thrornboxane ratio over most
of the course of shock (Cook et al., 1984); Butler et al., 1982).
Since prostacyclin is a potent vasodilator and thromboxane is a
potent

vasoconstrictor,

vasodilators

such as POB

may

be

contraindicated in shock states characterized by such a ratio of
arachidonic acid metabolites.
The endotoxin-induced attenuation of the MAP response to
injected NE (Figs 8,
in the literature,

10, and 12) is consistent with other reports
and various mechanisms have been proposed to

explain this depression of vascular reactivity.
(1983)

Manson and Hess

postulated that endotoxemia results in the release of

oxygen free radicals which then result in depressed contractility
in cardiac muscle and depressed reactivity of vascular smooth
muscle.

Soulsby

demonstrating

et.

ale

(1980)

support

depressed canine aortic

this

hypothesis

by

microsome calcium uptake

rate during endotoxin shock as a result of a parallel depression
in membrane bound calcium stimulated ATPase activity.
a1.

(1980)

using a

cecal ligation

Fink et.

rat sepsis model showed a

diminished pressor response to both NE and angiotensin II in
septic rats.

Since

responsiveness was restored toward normal in

34

animals

pretreated

with

indomethacin,

these

investigators

concluded that this phenomenon of diminished responsiveness may
be mediated by vasodilating prostaglandins, i.e., prostacyclin
and PGE2.

McM illan and Roth (1 986) also using a cecal ligation

rat model demonstrated a decrease in hepatic alpha 1 adrenergic
receptors

following

sepsis.

They

suggested that decreased

vascular responsiveness in sepsis may be a result of alterations
in

alpha

1

receptor

number

or

receptor-effector

Chernow and Roth (1986) in a review article cite,

coupling.

in addition to

some of the mechanisms discussed above, the role of endogenous
opoid peptides which may impair normal adrenergic function during
shock.

This possibility is supported by experiments in which

opiate antagonists such as TRH has been shown to transiently
increase vascular resistance in hemorrhagic shock (Siren et.
al., 1986).
The data suggest that endotoxin administration in rats
pretreated with POB have significantly higher heart rates than
rats given only POB at 30 mins post-endotoxin (Table IV), and
both unshocked controls and rats given only POB at 4 hrs postendotoxin (Table V).

Since there were no other significant

differences in HR between the four- treatments grbups at the time
points observed, the physiological significance of these findings
is not clear.
The

lack

of

significant

differences

in

mean

arterial

pressure in animals observed to four hrs post-endotoxin (Fig. 9),
in contrast to the group observed to 30 mins post-endotoxin, may
indicate an inadequate response in animals given only endotoxin.
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However,

this lack of differences in mean arterial pressure could

represent

transient

normalization

compensatory mechanisms which then

of

blood pressure

eve~tually

via

fail to maintain

pressure at a time point beyond the experimental period.

The

anesthesia and surgical stress of catheterization may also have
rendered the rats more resistant to the influence of endotoxin.
The cyclooxygenase inhibitor, indomethacin, failed to affect
the MAP response to NE as we 11 as MAP and 8R over the course of
shock.

The dose of INDO used (10 mg/kg) has been previously

shown to almost completely suppress the synthesis of thromboxane
and prostacyclin in our laboratory (Cook et al.,
et al.,

1984).

Tempel

(1982) demonstrated the pretreatment with 10 mg/kg INDO

ameliorated endotoxin-induced reduction in cardiac output and
blood flow to the heart, kidney, lung, liver, spleen, and GI
tract in the rat.

Similarly, Fletcher and Ramwell (1980b),

in a

baboon endotoxic shock model, showed a correlation in elevated
thromboxane levels with the acute rise in pulmonary arterial
pressure.

Increased levels of 6-keto-PGF1a

late in shock was

correlated temporally with the decline in arterial pressure.
Treatment with 1.5 mg/kg INDO one hour after endotoxin
administration reversed both the alterations in

~he

levels of the

arachidonic acid metabolites and the corresponding hemodynamic
sequelae.

Goto et al.,

(1980) suggested inhibition of

prostacyclin synthesis by INDO allows catecholarnines to act
unopposed,

i.e.,

augmenting the action of these vasoactive amines

on the cardiovascular system.

Their experiments demonstrated the

lack of any effect of INDO on blood pressure, cardiac output, or
left ventricular isometric tension rise in shocked, reserpine36

treated, and adrenalectomized dogs.

Alpha and beta blocking

agents in these studies suppressed the high hemodynamic state
induced by INDO treatment.

Feuerstein et al.,

(1981) also report

a improved hemodynamic status as a result of INDO administration
in cat subjected to endotoxin.

Their data, however, show a

suppression of plasma epinephrine and norepinephrine as a result
of INDO treatment.

Similarly, INDO treatment of patients with

Bartter's syndrome corrected the hypercatecholaminuria associated
with this condition (Gullner et al., 1980).

These patients have

high levels of circulating prostaglandins, particularly PGE2 and
PGI 2 , which are thought to have an inhibitory influence on
sympathetic neurotransmission.

As a result, these investigators

suggest that the high levels of catecholamines in these patients
are a result of compensation for a prostaglandin-mediated pressor
resistance to norepinephrine.
The lack of significant alterations in hemodynamic parameters
and response to exogenous NE following treatment with INDO may be
indicative of inadequate response to endotoxin.

The finding of

no reduction in response to NE in rats treated with only
endotoxin in this last group of experiments supports this
contention.
In conclusion, the results of this study have described the
influences

of

the

alpha

blocker

POB

(1

mg/kg)

and

the

cyclooxygenase inhibitor INDO (10 mg/kg) on three hemodynamic
variables in normal rats and rats subjected to endotoxin:
arterial

pressure,

heart

rate,

and

response to injected norepinephrine.
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mean

arterial

mean

pressure

Our results suggest that

the 1 mg/kg dose of POB provides adequate alpha receptor blockade
without exacerbating the hypotension seen in endotoxin-treated
rats or significantly influencing heart rate.

INDO (10 mg/kg)

did not appear to affect any of these three parameters in normal
rats and endotoxin-treated rats.
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CHAPTER FOUR

THE EFFECTS OF ALPHA ADRENERGIC BLOCKADE ON ARACHIDONIC
ACID METABOLISM AND SURVIVAL IN SHOCK INDUCED BY
INTRAABDOMINAL SEPSIS

INTRODUCTION

Data from previous experiments (Chapter 2) suggest that
pretreatment with 1 mg/kg of the alpha receptor blocker, POB,
results in improved survival time, decreased mortality, decreased
shock severity,
PGFla

and reduced plasma levels of iTxA2 and i6-keto-

in the rat bolus endotoxin model.

in iTxB2 and i6-keto-PGFla
they were not complete,

Although the reductions

effected by POB were significant,

i.e.,

approximately 40% reduction in

iTxB2 at 30 minutes post-endotoxin in and 70% reduction in i6keto- PGF la

at 4 hrs post endotoxin. Some investigators have

expressed the opinion that the absolute presence or absence of
detectable levels of iTxB2 and i6-keto-PGFla
as

the

ratio of

these

tissue

autocoids

is not as important
in determining

efficacy of various pharmacologic agents in septic shock.
et al.,

the
Cook

(1984) proposed that the failure of selective thromboxane

synthetase inhibitors to improve survival in a fecal peritonitis
model of sepsis when improved survival was the result in the rat
endotoxin model is due,

in part, to different patterns in the

plasma levels of iTxB2 and i6-keto-PGF1a

over the course of

shock (see Chapter 1 for description of models).
selective

thromboxane

synthetase

In particular,

inhiBitors

may

be

contraindicated in shock states characterized by high PGI2/TxA2
ratios.
These findings combined

with the controversy concerning the

efficacy of treatment with POB in various septic shock models
(Abrams et al.,

1969;

Brake et al.,

1964; Skjoldburg et al.,

1968), suggest that the underlying pattern of arachidonic acid
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metabolites

may

dictate

the

therapeutic

efficacy

of

alpha

receptor blockade with POB in sepsis.
The purpose of this study was to extend the results of
treatment with POB in the rat bolus endotoxin model by assessing
the effect of this alpha receptor blocker in a fecal peritonitis
model of sepsis.

Specifically, the effects of POB on survival

time and mortality and on the synthesis of iTxB2 and i6-ketoPGF l a '

the stable rnetaboli tes of thromboxane and prostacyclin,

were examined (Specific Aim 1).

The relative protective efficacy

of POB and indomethacin (INDO) were also compared in single and
conjoint therapy with respect to survival time and mortality
(Specific Aims 2 + 3).
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METHODS AND MATERIALS
Animals
(see Chapter 2 - Methods and Materials)
Induction of Shock from Fecal Peritonitis Induced

BY

Intra-

Abdominal Injection of Feces
Fecal peritonitis was induced by a single intraperitoneal
injection of fecal suspension as described by Butler et al.,
(1982).

The standard dose employed in this study was .74 gm dry

weight/kg body weight, which has been used by Butler et ale to
produce a mean survival time in the rat of 9.2 + 0.5 hrs with
100% mortality within 48 hrs.

Treatment Protocol
Phenoxybenzamine HCI (Smith, Kline, and French) was freshly
prepared in 30% ethanol and isotonic saline,
a dose of 1 mg/kg body wt.

and administered at

Although the effects of this dose on

mean arterial pressure and heart rate over the course of shock
and

on

the

mean

arterial

pressure

response

to

injected

norepinephrine has been studied in the bolus endotoxin model
(Chapter 3), a similar study has not been done with the fecal
peritonitis model of sepsis.
The cyclooxygenase inhibitor INDO was freshly prepared in a
sodium phosphate bufffer solution
intravenously (10 rng/kg body wt).

(ph

8.0)

and administered

This dose has been shown to

result in effective blockade of arachidonic acid metabolism in
both normal rats and rats subjected to fecal peritonitis (Butler
et al., 1982).
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Survival Time and Mortality
Rats were pretreated with either INDO or POB,

independently

or conjointly, prior to challenge by intraperitoneal injection of
feces (.74 gm dry wt/kg body wt).

Determination of survival time

was made by observation as the

rats progressed through a

characteristic series of symptoms including lethargy,
loss of righting reflex,

convulsions,

tachypnea,

and respiratory arrest.

Radioimmunoassay of immunoreactive

ill

iTxB2 and i6-keto-

PGFla
The methodology for this experiment is the same as described
under Methods and Materials in Chapter 2,

except that blood

samples were collected at 1 hr and 6 hr post-intraperitoneal
injection of feces rather than
These

time

points

were

0.5 hr and 4 hr post-endotoxin.

selected to correlate with previous

findings in our laboratory with this shock model concerning the
pattern of plasma levels of
al.,

iTxB2 and i6-keto-PGFla

(Butler et

1982).
Statistical Methods
Survival time and mortality were examined by analysis of

variance-completely random design

(ANOVA-CRD).

The Newman-Keuls

test was used to examine differences between treatment groups.
The unpaired Student's t-test was used to test for differences in
iTxB2 and i6-keto-PGFla

between treatment groups.

All data were

expressed as mean + error of the mean and confidence limits were
set at 95% for significance.
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RESULTS
Survival Time and Mortality
In this model of sepsis,

vehicle

30

mins

before

untreated control animals given

intra-abdominal

injection

of

feces

exhibited 100% mortality within 48 hrs with a mean survival time
of

9.2

+

depress

0.3

hrs

(Table VII).

POB pretreatment appeared to

survival time to 7.5 + 0.5

mortality

within

48

hrs.

hrs and resulted in 100%

However,

this

group

statistically different from controls (P)0.05).

was

not

Pretreatment

with INDO resulted in an improvement in mean survival time to
20.2 + 1.4 hrs (p<O.05) compared to controls and to rats treated
with only POB, but failed to alter mortality (100% within 48
hrs).

Pretreatment with the combination of POB + INDO failed to

decrease mortality (100% within 48 hrs),

but increased mean

survival time to 23.7 + 2.2 hrs (P<O.05 compared to controls and
to animals treated with only POB).

There was no significant

difference in survival time or mortality between rats treated
with only INDO and rats treated with POB + INDO.
Plasma Arachidonic Acid Metabolites
Septic rats given vehicle alone

exhibited~_

plasma iTxB2 of

1184 + 719 pg/ml 1 hr post-injection, and 2004 + 368 pg/ml at 6
hr after injection (Table VIII).

Pretreatment with POB did not

significantly (P>O.05) alter plasma levels of iTxB2 at 1 hr and 6
hr post-injection compared to controls (434 + 135 pg/ml and 1749
+ 747 pg/ml,

respectively.
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TABLE VII
Effects of Phenoxybenzamine (POB) and Indomethacin (INDO)
Pretreatment on Survival During Fecal Peritonitis (FP) Shock

Group

Mean Survival Time
9.2 + 0.3 ( 10)
-

Control + FP

20.2 + 1 • 4 ( 1 4 )
-

INDO + FP
POB + FP

7.5 + 0.5 ( 9 )

-

23.7 + 2.2 ( 14 ) *
-

INDO + POB + FP
Data presented as mean + S.E.

*

*

(N)

P<O.05 compared to controls and rat treated with only POB
Rats were pretreated with INDO (10 mg/kg).
INDO vehicle.
POB (1 mg/kg), POB vehicle or POB and INDO via I.V. 30
minutes before intraperitoneal injection of feces (.74 gms
dry wt/hg/body wt).
There were no survivors after 48 hrs
post-injection. Control = POB vehicle + INDO vehicle.

4Ja

TABLE VIII
Effect of Phenoxybenxamine (POB) on Arachidonic
Acid Metabolites in Septic Shock

Group

iTXB2
(pg/ml plasma)

6-keto- PGF la
(pg/ml plasma)

1184 + 719 (2 )

7554 + 1325 ( 4 )
-

1 Hour

Control + FP
POB + FP

-

434 + 135 (3 )
-

7616 +

-

279 (3 )

Control + FP

2004 + 368 (3)

10004 +

630 (3)

POB + FP

1749 + 747 (2)

6 Hours

6462 + 3227 (2)

POB or POB vehicle (control) was administered i.v. (1 mg/kg)
30 minutes prior to intraperitoneal injection of feces (.74
9 dry wt/kg body wt).
P las rna samples we re collected at 1
hour and 6 hours post-injection.
Data expressed mean + S.E.

(N)
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There was no significant difference in plasma concentration
of

i6-keto-PGFla

animals

between controls

treated with POB

injection

of

feces

(7616

(P>O.OS).

(7754 +

1325

+ 279 pg/ml)

SirrLilarly,

no

pg/ml)

and

at 1 hr postdifference

was

observed in the POB group at 6 hrs compared to the vehicle group
(10004 + 630 pg/ml vs 6462 + 3227).
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DISCUSSION

In contrast to the results observed with the
endotoxin model of sepsis,

rat bolus

pretreatment with POB

in the

peritonitis model afforded no significant protection with regard
to survival time and mortality.

In this LD100 sepsis model, INDO

pretreatment was clearly more beneficial in improving survival
time than pretreatment with POB (P<O.05).

In the bolus endotoxin

model, both agents improved survival compared to controls with no
significant difference between the two inhibitors.

The data

suggest that the combination of INDO and POB is more effective
than POB alone; however, this combination was no better than INDO
acting individually.

The failure of POB to effect an improvement

in survival in this model of sepsis may result as a consequence
of

the

following:

The

levels of prostacyclin,

a

potent

vasodilator, have been shown to be markedly elevated in fecal
peritonitis shock.

By contrast, the levels of thromboxane, a

potent vasoconstrictor, are comparatively low (Butler et al.,
1 982 ).

Furthermore,

the synthesis of these arachidonic acid

metabolites is not completely suppressed

by pretreatment with

POB, as suggested by the results with the bolus endotoxin model
(Chapter 2) and the results of this study (vide supra).

The

prevailing plasma levels of these metabolites in this shock
model, which indicate a high PGI2/Tx ratio, combined with the
additional vasodilation effected by POB-induced alpha receptor
blockade may intensify hypotension,

and exacerbate the mismatch

between perfusion and metabolism.
There were no significant differences in plasma levels of
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iTxB2 and i6-keto-PGFla

between controls and rats treated with

POB at either 1 hr or 6 hr after induction of intraabdominal
sepsis.

The variability in the response of the animals and the

small number of rats in each group may have contributed to this
lack

of

statistically

possible

that

significant differences.

significant

differences

in

It

is also

arachidonic

acid

metabolite levels may have arisen beyond the experimental period.
The mean plasma levels of

iTxB2

in controls at

1 hr post-

injection (1184 pg/ml) was greater than 2.5 times that of the POB
treated animals (434 pg/ml).
keto-PGFla

Similarly, the mean levels of i6-

in controls at 6 hrs post-injection (10004 pg/ml) is

about 1.5 times that of POB-treated rats (6462 pg/ml).
preliminary

results which warrant further

These are

investigation to

determine if significant differences do exist in a larger group
of animals observed over a longer experimental period.

Despite

the lack of protection seen with POB with regard to survival
time/mortality, demonstration of a POB-mediated reduction in
iTxB2 and i6-keto-PGF1a in this shock model in addition to the
endotoxin model would provide further support for a link between
increased adrenergic activity and elevated arachidonic acid
concentrations.
Previous

reports

have

indicated

that

an elevation of

arachidonic acid metabolite levels occurs during sepsis and have
suggested their role in subsequent pathophysiology (Cook et a1.,
1984).

Our results are consistent with the hypothesis that

plasma levels of the two arachidonic metabolites,

iTxB2 and i6-

keto-PGF1a ' may be used to determine the therapeutic efficacy of
POB.

In particular, INDO rather than POB appears to be the agent
46

of choice in this sepsis model because of the associated high
PGI2/Tx ratio.

The preliminary results suggest that POB may

attenuate the elevation of plasma TxB2 and 6-keto-FGFla

in fecal

peritonitis shock despite inability to significantly prolong
survival time,

providing additional support for

a

relation

between heightened sympathetic activity and elevated eicosanoid
levels in septic and endotoxin shock.
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CHAPTER FIVE

GENERAL CONCLUSIONS AND DIRECTIONS FOR FUTURE RESEARCH

Previous reports have indicated the potential role of
increased alpha adrenergic activity in stimulating arachidonic
acid metabolism during endotoxemia and septicemia_

The results

of the preceeding experiments are consistent with the above
hypothesis, demonstrating decreased mortality during endotoxemia
as a result of POB pretreatment.

This improvement in survival

afforded by POB is associated with attenuated levels of iTxB2 and
i6-keto-PGFla-

These results also imply that the treatment with

the combination of POB and INDO may be more effective than either
one of these therapeutic agents individually. In contrast,
pretreatment with POB appeared to have no protective effect in
preliminary experiments utilizing the fecal peritonitis model of
septicemia, thus suggesting that the different pattern in the
elevations of iTxB2 and i6-keto-PGFla in this shock model
compared to the bolus endotoxin model may dictate the therapeutic
efficacy of POB.

In this model, INDO appeared to be the agent of

choice in improving survival.

Additional work utilizing this

model is warranted, especially in examining the possible
attenuation of iTxB2 and i6-keto-PGFla levels by POB
pretreatment.

Although POB may not enhance survival in this

shock model, further experiments

m~y

be

benefici~l

in delineating

the mechanism of POB-induced attenuation of these arachidonic
acid metaboli tes •.
Studies examining the effect of POB on iTxB2 and i6keto-PGFla

levels in the endotoxin model could be extended to

include additional time points.

In addition to giving a more

complete picture of arachidonic acid metbolite levels throughout
the course of endotoxemia in both controls and POB treated
48

animals,

this approach may substantiate or rule out the

posibility that POB may only serve to delay rather than suppress
the rise in iTxB2 and i6-keto-PGFla •
These experiments used one alpha receptor blocker, POB, a
nonspecific alpha-one and alpha-two receptor antagonist.

This

raises the question of whether or not the attenuation of iTxB2
and i6-keto- PGF 1a

levels in POB-treated animals was a result of

a direct effect of the drug on reducing catecholamine-induced
synthesis of these arachidonic acid metabolites mediated by alpha
receptors.
system

It is possible that blunting of sympathetic nervous

action on vascular beds or other target organs may have

resulted in a improved cardiovascular status which subsequently
resulted in a secondary reduction in eicosanoid synthesis.

POB

may also have depressed the levels of iTxB2 and i6-keto- PGF la
through non-specific activity independent of
antagonism.

alpha receptor

The use of more specific alpha blockers such as

prazosin (Minipress) in similar experiments may shed more light
on these potential mechanisms of action.
These experiments were carried out under the assumption that
endotoxemia/septicemia induced in rats is associated with
L

increased sympathetic activity which is manifested by elevated
levels of plasma catecholamines.

Jones and Romano (1984) have

demonstrated increased catecholamine levels and

increased

catecholamine turnover in a rat bolus endotoxin similar to the
one used for the preceeding experiment; otherwise there are no
other reports of catehcholamine levels during shock resulting
from endotoxemia and septicemia in rats. The finding of similar
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elevations in catecholamines

in the two shock models used for

the preceeding experiments would provide the basis for the above
assumption and further support a role for increased adrenergic
activity in the elevation of arachidonic acid metabolites during
endotoxic and septic shock.
Further work is indicated in identifying tissue populations
which, under in vitro conditions, could be stimulated by both
endotoxin and exogenous catecholamines to elaborate increased
amounts of iTxB2 and i6-keto-PGF1a.
(Tempel et al.,

Previous work in our lab

1984 abstract) has suggested that POB suppresses

endotoxin-stimulation of these arachidonic acid metabolites in
rat peritoneal macrophages.

However, this population of cells

failed to demonstrate increased synthesis of iTxB2 and i6-ketoPGFla

in response to exogenous nonepinephrine. Similar studies

identifying cell populations responsive to both endotoxin and
exogenous catecholamines

by increased synthesis of these

metabolites and to POB by reduced levels of iTxB2 and i6-ketoPGFla would indicate potential sites of action for POB, both in
terms of the physical location of the receptors and their
functional location in relation to the arachidonic acid cascade.
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